Please login to the form below

Not currently logged in
Email:
Password:

stroke

This page shows the latest stroke news and features for those working in and with pharma, biotech and healthcare.

CTI slumps as Servier-partnered lymphoma drug fails

CTI slumps as Servier-partnered lymphoma drug fails

After major setback CTI, has promising myelofibrosis candidate to fall back on. " /. After major setback CTI, has promising myelofibrosis candidate to fall back on. " /. CTI slumps as Servier-partnered lymphoma drug fails. After major setback CTI,

Latest news

More from news
Approximately 14 fully matching, plus 513 partially matching documents found.

Latest Intelligence

  • 30 women leaders in UK healthcare (part 3) 30 women leaders in UK healthcare (part 3)

    frail and elderly and also in stroke care. There is no doubt that Claire and her ICO colleagues face huge challenges, not only in bringing about closer integration between a huge

  • The NHS and ABPI at 70: inching closer to the triple win The NHS and ABPI at 70: inching closer to the triple win

    Commenting on reorganisation of hospital services across the region, Jon Rouse said: “We’ve already got the best stroke services in the country, and we’ll soon have the best cardiac

  • Shaping healthcare Shaping healthcare

    When you look at our products, [with] Xarelto, since its launch in  its major indications, we have prevented about 13, 000 strokes. ... So, you could look at it as almost a city-sized dwelling of people that have the potential to live happy lives

  • Digital disruption in market access Digital disruption in market access

    Accession is currently working with the NHS in the UK to prevent the devastating impact of stroke caused by atrial fibrillation (AF) through the use of digital technology. ... AF strokes are likely to be the most serious strokes, cause long-term harm and

  • Is it possible to change behaviour virtually? Is it possible to change behaviour virtually?

    Clinicians' ability to identify the correct patients for different stroke prevention treatments had been identified as a barrier to optimal management of non-valvular atrial fibrillation (NVAF).

More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 16 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics